Michael David Geschwind

Dr. Michael David Geschwind

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2017 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Open access
PDF file
MEMichael G. Erkkinen
Michael G. Erkkinen
MKMee-Ohk Kim
Mee-Ohk Kim
MGMichael David Geschwind
Michael David Geschwind
Neurodegenerative diseases are a common cause of morbidity and cognitive impairment in older adults. Most clinicians who care for the elderly are not trained to diagnose these conditions, perhaps other than typical Alzheimer’s disease (AD). Each of these disorders has varied epidemiology, clinical symptomatology, laboratory and neuroimaging features, neuropathology, and management. Thus, it is important that clinicians be able to differentiate and diagnose these conditions accurately. This review summarizes and highlights clinical aspects of several of the most commonly encountered neurodegenerative diseases, including AD, frontotemporal dementia (FTD) and its variants, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA), and Huntington’s disease (HD). For each condition, we provide a brief overview of the epidemiology, defining clinical symptoms and diagnostic criteria, relevant imaging and laboratory features, genetics, pathology, treatments, and differential diagnosis.

1 December 2015 in Continuum
Verified
Journal Article
Closed access
MGMichael David Geschwind
Michael David Geschwind
T disease), genetic (genetic Jakob-Creutzfeldt disease, Gerstmann-Stra¨ussler-Scheinker syndrome, and fatal familial insomnia), and acquired (kuru, variant Jakob-Creutzfeldt disease, and iatrogenic Jakob-Creutzfeldt disease) forms. This article presents updated information on the clinical features and diagnostic methods for human prion diseases. New antemortem potential diagnostic tests based on amplifying prions in order to detect them are showing very high specificity. Understanding of the diversity of possible presentations of human prion diseases continues to evolve, with some genetic forms progressing slowly over decades, beginning with dysautonomia and neuropathy and progressing to a frontal-executive dementia with pathology of combined prionopathy and tauopathy. Unfortunately, to date, all human prion disease clinical trials have failed to show survival benefit. A very rare polymorphism in the prion protein gene recently has been identified that appears to protect against prion disease; this finding, in addition to providing greater understanding of the prionlike mechanisms of neurodegenerative disorders, might lead to potential treatments. Summary: Sporadic Jakob-Creutzfeldt disease is the most common form of human prion disease. Genetic prion diseases, resulting from mutations in the prion-related protein gene (PRNP), are classified based on the mutation, clinical phenotype, and neuropathologic features and can be difficult to diagnose because of their varied presentations. Perhaps most relevant to this Continuum issue on neuroinfectious diseases, acquired prion diseases are caused by accidental transmission to humans, but fortunately, they are the least common form and are becoming rarer as awareness of transmission risk has led to implementation of measures to prevent such occurrences....

1 April 2016 in Continuum
Verified
Journal Article
Closed access
MGMichael David Geschwind
Michael David Geschwind
Purpose of Review: This article presents a practical and informative approach to the evaluation of a patient with a rapidly progressive dementia (RPD). Recent Findings: Prion diseases are the prototypical causes of RPD, but reversible causes of RPD might mimic prion disease and should always be considered in a differential diagnosis. Aside from prion diseases, the most common causes of RPD are atypical presentations of other neurodegenerative disorders, curable disorders including autoimmune encephalopathies, as well as some infections, and neoplasms. Numerous recent case reports suggest dural arterial venous fistulas sometimes cause RPDs. Summary: RPDs, in which patients typically develop dementia over weeks to months, require an alternative differential than the slowly progressive dementias that occur over a few years. Because of their rapid decline, patients with RPDs necessitate urgent evaluation and often require an extensive workup, typically with multiple tests being sent or performed concurrently. Jakob-Creutzfeldt disease, perhaps the prototypical RPD, is often the first diagnosis many neurologists consider when treating a patient with rapid cognitive decline. Many conditions other than prion disease, however, including numerous reversible or curable conditions, can present as an RPD. This chapter discusses some of the major etiologies for RPDs and offers an algorithm for diagnosis.

4 August 2017 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Closed access
PDF file
MKMee-Ohk Kim
Mee-Ohk Kim
LTLeonel T. Takada
Leonel T. Takada
KWKatherine Wong
Katherine Wong
SFSven A. Forner
Sven A. Forner
MGMichael David Geschwind
Michael David Geschwind
Genetic prion diseases (gPrDs) caused by mutations in the prion protein gene (PRNP) have been classified as genetic Creutzfeldt–Jakob disease, Gerstmann–Sträussler–Scheinker disease, or fatal familial insomnia. Mutations in PRNP can be missense, nonsense, and/or octapeptide repeat insertions or, possibly, deletions. These mutations can produce diverse clinical features. They may also show varying ancillary testing results and neuropathological findings. Although the majority of gPrDs have a rapid progression with a short survival time of a few months, many also present as ataxic or parkinsonian disorders, which have a slower decline over a few to several years. A few very rare mutations manifest as neuropsychiatric disorders, with systemic symptoms that include gastrointestinal disorders and neuropathy; these forms can progress over years to decades. In this review, we classify gPrDs as rapid, slow, or mixed types based on their typical rate of progression and duration, and we review the broad spectrum of phenotypes manifested by these diseases.

12 December 2016 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Closed access
PDF file
LTLeonel T. Takada
Leonel T. Takada
MKMee‐Ohk Kim
Mee‐Ohk Kim
RCRoss W. Cleveland
Ross W. Cleveland
KWKatherine Wong
Katherine Wong
SFSven A. Forner
Sven A. Forner
MGMichael David Geschwind
Michael David Geschwind

1 December 2012 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
RPR W. Paterson
R W. Paterson
CTCharles C. Torres-Chae
Charles C. Torres-Chae
AKAmy L. Kuo
Amy L. Kuo
TATim Ando
Tim Ando
ENElizabeth A. Nguyen
Elizabeth A. Nguyen
MGMichael David Geschwind
Michael David Geschwind
There are often long delays between the time that a patient with sporadic Jakob-Creutzfeldt disease (sCJD) first presents to the physician and the time that a correct diagnosis is made. Sporadic CJD is misdiagnosed for many reasons, including the variability of early symptoms and signs,1-4 the variability in disease duration, and lack of recognition of this condition in the medical community.5 Depending on where prions accumulate in the brain, the clinical presentation can be variable6,7 and sCJD is easily mistaken for other neurodegenerative conditions such as Alzheimer disease, corticobasal degeneration, and dementia with Lewy bodies.8-10